[ARWR] YoY Annual Result on 30-Sep-2024 [#FY]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
26-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#FY]
Profit Trend
YoY- -192.04%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Annual Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,551 240,735 243,231 138,287 87,992 168,796 16,142 -22.28%
PBT -602,260 -206,491 -172,709 -140,846 -84,551 68,148 -54,448 49.21%
Tax -2,767 2,784 3,785 2 2 174 2 -
NP -599,493 -205,275 -176,494 -140,848 -84,553 67,975 -54,450 49.09%
Tax Rate - - - - - -0.25% - -
Total Cost 603,044 446,010 419,725 279,135 172,545 100,821 70,593 42.92%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -16,882.37 -85.27 -72.56 -101.85 -96.09 40.27 -337.32 91.85%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -5.00 -1.91 -1.67 -1.36 -0.84 0.72 -0.65 40.45%
EPS Diluted -5.00 -1.92 -1.67 -1.36 -0.84 0.69 -0.65 40.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.